[Eczema diseases and erythemato-squamous dermatoses of aging skin--studies of the effectiveness and tolerance of Prednicarbate in various vehicles].

Abstract

In an open multi-center study on 1,286 patients aged 60 years and more, we tested the efficacy and compatibility of prednicarbate (Dermatop) in various vehicles. The eczemas and erythematosquamous dermatoses of 857 patients (66.6%) disappeared within three weeks treatment. In 142 patients (11%), it took more than 3 weeks (62 day at the most) to achieve a complete healing. A very good or good tolerance was observed in 97.1% of the patients. Only in 1.5% the study had to be broken off because of a change for the worse. Prednicarbate, therefore, is especially suitable in the treatment of eczemas and chronic erythematosquamous dermatoses of aged skin.

• Authors: A Stary, H Schulz, H Tronnier
• Journal: Zeitschrift fur Hautkrankheiten (Z Hautkr) Vol. 64 Issue 11 Pg. 1010, 1013-4 (Nov 15 1989) ISSN: 0301-0481 [Print] Germany
• Vernacular Title: Ekzemkrankheiten und erythemato-squamöse Dermatosen der Altershaut--Untersuchungen zur Wirksamkeit und Verträglichkeit von Prednicarbat in verschiedenen Zubereitungsformen.
• PMID: 2692325 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Pharmaceutical Vehicles
• Prednisolone
• prednicarbate

Topics

• Aged
• Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, adverse effects)
• Dermatitis (drug therapy)
• Eczema (drug therapy)
• Female
• Humans
• Male
• Middle Aged
• Multicenter Studies as Topic
• Pharmaceutical Vehicles
• Prednisolone (administration & dosage, adverse effects, analogs & derivatives)
• Skin Aging (drug effects)